Eckart BeuttenmuellerDirector, Gross-to-Net Execution at Bayer Healthcare Pharmaceuticals, Inc.
Agenda Sessions
Closed Door Discussion: Next Steps in 340B - Operational Challenges and Best Practices at the Intersection of the IRA and 340B
, 4:30pmView Session